HOME >> MEDICINE >> NEWS
Synthetic marijuana reduces agitation in patients with Alzheimers

San Antonio, Texas and Long Branch, N.J. (November 14, 2003) Results from a Phase II, multi-center study found dronabinol, a synthetic version of the active ingredient in marijuana, reduces agitation in patients with Alzheimer's disease. In addition, the research concluded that reduced agitation may contribute to the relief of caregiver burden associated with the condition. The findings were presented at the American Society of Consultant Pharmacists' 34th annual meeting.

"Our results show dronabinol is an effective treatment for behavioral agitation in patients with Alzheimer's and may ultimately help reduce the stress often experienced by caregivers," said geriatrician Joel S. Ross, M.D. a member of the teaching faculty at Monmouth Medical Center and the lead investigator in the study. "While difficult for the patient, the effects of agitation can greatly impact the emotional and physical health of family members and caregivers. By reducing patients' agitation, caregivers are able to focus more time and energy on their patients' overall wellbeing."

Dronabinol, marketed as Marinol, is synthetic delta-9-tetrahydrocannabinol (delta-9-THC). Delta-9-THC also is a naturally occurring component of Cannabis sativa L (marijuana). Dronabinol has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of anorexia in patients with HIV/AIDS and for the treatment of nausea and vomiting associated with cancer chemotherapy. Recent clinical tests also have examined dronabinol's potential to relieve symptoms of multiple sclerosis.1

Agitation is the most common behavioral management problem in patients with Alzheimer's and affects an estimated 75 percent of people with the disease. It may lead to a variety of symptoms ranging from physical and/or verbal abusive postures, physically non-aggressive conduct including pacing and restlessness, as well as verbally disturbed behaviors such as screaming and repetitive requests for att
'"/>


14-Nov-2003


Page: 1 2 3

Related medicine news :

1. Synthetic progestin damages, estrogen protects blood vessels in animal model
2. Synthetic marijuana compound reduces agitation, improves appetite in Alzheimers patients
3. Synthetic rubber kills germs on contact
4. Views Of Tamoxifen And Synthetic Estrogen In Action Provide Clues For Designing Better Drugs
5. UCSF Study In Rats Suggests Synthetic Drug Mimicking Marijuana Might Be Used To Treat Pain
6. "Green Chemistry" Cleans Up Environment And Renders Synthetic Drugs
7. Synthetic Detergent Found To Fight Multi-Drug Resistance
8. Yale to study marijuana, ecstasy and teen cognitive deficits
9. Adult marijuana abuse, dependence increased during 1990s
10. Increase in prevalence of marijuana abuse and dependence
11. Rare risk: Adolescent binging on marijuana linked to stroke

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/16/2019)... ... 15, 2019 , ... SilcSkin – silicone anti-wrinkle pad pioneer and creator of ... Product for 2019 in the Neck and Decolleté category for the second time. The ... attendees of the International Congress of Esthetics and Spa. Developed by two-time Emmy award ...
(Date:2/16/2019)... ... 2019 , ... SurgCenter Development ( http://www.surgcenter.com ) (SCD), a ... the formation of its 200th ASC partnership in its 26-year history with the ... continue to see the demand increase from patients who want high quality, convenient ...
(Date:2/14/2019)... Texas (PRWEB) , ... February 14, 2019 , ... ... Vegas, QT Medical announced the launch of its Personal Cardiac Assistant (PCA 500), ... health trackers including Apple Watch 4 can record single lead ECGs and identify ...
(Date:2/14/2019)... , ... February 14, 2019 , ... ... operating support which will directly impact Spaulding’s programs and services. , “The generous ... our organization and in the lives of the children we serve for years ...
(Date:2/13/2019)... ... 2019 , ... CBD Hacker , the definitive guide to the CBD ... is the result of rigorous testing of more than 20 products, including third-party potency ... are looking for a fast-acting, effective delivery method for CBD. And the fact that ...
Breaking Medicine News(10 mins):
(Date:2/13/2019)... , ... February 13, 2019 , ... ... Bogotá, Colombia. The new program opens possibilities for childless couples who are unable ... Until now, childless couples have been limited to North America or Eastern Europe ...
(Date:2/13/2019)... ... February 13, 2019 , ... ... the Public Private Partnership (PPP) between the Department of Health-Abu Dhabi (DoH) and ... first Health Information Exchange system (HIE), a centralized platform to streamline healthcare connectivity ...
(Date:2/13/2019)... ... February 13, 2019 , ... ClearCube® Technology, Inc. ... 2019 US in Orlando, Florida. The compact Thin Clients demonstrate their versatility in ... $520 and above respectively. , Powered by Intel® Celeron® N2807 dual-core processors ...
Breaking Medicine Technology:
Cached News: